To compare which is more better between Lactosporin 2% Gel Versus Adapalene 0.1% Gel to treat Acne Vulgaris

To Compare The Therapeutic Efficacy Of Lactosporin 2% Gel Versus Adapalene 0.1% Gel In The Treatment Of Mild To Moderate Acne Vulgaris- A Randomized Comparative Study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059321

Enrollment

Registered

2023-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Adapalene 0.1% gel: In patients with mild to moderate Acne Vulgaris Adapalene 0.1% Gel will be applied once a day(at night) for a period of 4 weeks Control Intervention1: Lactosporin 2%

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with Mild to moderate acne vulgaris 2)Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: 1)Pregnant and lactating mothers 2)Patients allergic to Lactosporin and Adapalene 3)Patients who used topical corticosteroids ,antibiotics or retinoids within the past two weeks on the face 4)Patients who used systemic corticosteroids, antibiotics or retinoids within the past 1 month

Design outcomes

Primary

Measure	Time frame
Compare the clinical response with the help of Global acne grading system and comparing the therapeutic efficacy of Adapalene 0.1% Gel versus Lactosporin 2% Gel in the treatment of mild to moderate Acne VulgarisTimepoint: Every week during the course of treatment, at the end of 4 weeks of treatment	—

Secondary

Measure	Time frame
Treatment side effects, RecurrenceTimepoint: For a period of 4 weeks after cessation of treatment	—

Countries

India

Contacts

Public ContactDr Aakrith Dhaksh Dewan

Vinayaka Missions Medical College and Hospitals, Karaikal

hoddvdvmmckkl@gmail.com9884835199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026